These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 30236844)
21. A beta-lactamase from Proteus vulgaris that hydrolyses newly introduced cephalosporins. Pagani L; Perduca M; Romero E Microbiologica; 1983 Apr; 6(2):163-8. PubMed ID: 6306402 [No Abstract] [Full Text] [Related]
22. Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4. Gazouli M; Legakis NJ; Tzouvelekis LS FEMS Microbiol Lett; 1998 Dec; 169(2):289-93. PubMed ID: 9868772 [TBL] [Abstract][Full Text] [Related]
23. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. Nista EC; Candelli M; Cremonini F; Cazzato IA; Zocco MA; Franceschi F; Cammarota G; Gasbarrini G; Gasbarrini A Aliment Pharmacol Ther; 2004 Nov; 20(10):1181-8. PubMed ID: 15569121 [TBL] [Abstract][Full Text] [Related]
34. Gut immune homeostasis: the immunomodulatory role of Wong-Chew RM; de Castro JA; Morelli L; Perez M; Ozen M Expert Rev Clin Immunol; 2022 Jul; 18(7):717-729. PubMed ID: 35674642 [TBL] [Abstract][Full Text] [Related]
35. Bacillus clausii and gut homeostasis: state of the art and future perspectives. Lopetuso LR; Scaldaferri F; Franceschi F; Gasbarrini A Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):943-8. PubMed ID: 27291780 [TBL] [Abstract][Full Text] [Related]
36. The Comparative Effects of Inulin and Sogut I; Kar F; Tanrikulu-Kucuk S; Gozden TT; Asena Can S; Kandil A J Invest Surg; 2022 Jun; 35(6):1322-1328. PubMed ID: 35313790 [TBL] [Abstract][Full Text] [Related]
37. Current Progress and Future Perspectives on the Use of Bacillus clausii. Ghelardi E; Abreu Y Abreu AT; Marzet CB; Álvarez Calatayud G; Perez M; Moschione Castro AP Microorganisms; 2022 Jun; 10(6):. PubMed ID: 35744764 [TBL] [Abstract][Full Text] [Related]
38. Use of whey as a culture medium for Bacillus clausii for the production of protein hydrolysates with antimicrobial and antioxidant activity. Rochín-Medina JJ; Ramírez-Medina HK; Rangel-Peraza JG; Pineda-Hidalgo KV; Iribe-Arellano P Food Sci Technol Int; 2018 Jan; 24(1):35-42. PubMed ID: 28816527 [TBL] [Abstract][Full Text] [Related]
39. Selection of Klebsiella pneumoniae mutants with high-level cefotaxime resistance during growth in serum containing therapeutic concentrations of cefotaxime. Bedenić B Chemotherapy; 2002 Mar; 48(1):10-4. PubMed ID: 11901250 [TBL] [Abstract][Full Text] [Related]